| Evaluation of Breast Implant–Associated Anaplastic Large Cell Lymphoma With Whole Exome and Genome Sequencing |
 |
|
Neha Akkad, MD, Rohan Kodgule, MD, Eric J Duncavage, MD, Neha Mehta-Shah, MD, MSCI, David H Spencer, MD, PhD, Marcus Watkins, PhD, Cara Shirai, PhD, Terence M Myckatyn, MD, FACS, FRCSC Aesthetic Surgery Journal, sjac282 Background: Breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) is a rare malignancy originating from the periprosthetic capsule of a textured, most often macrotextured, breast implant. Identified in women whose indications for breast implants can be either aesthetic or reconstructive, the genomic underpinnings of this disease are only beginning to be elucidated. Objectives: The aim of this study was to evaluate the exomes, and in some cases the entire genome, of patients with BIA-ALCL. Specific attention was paid to copy number alterations, chromosomal translocations, and other genomic abnormalities overrepresented in patients with BIA-ALCL. >> View on the Aesthetic Surgery Journal Website |
"I GIVE..."
Jose López Tallaj
|
“I give knowing that ASERF is the research foundation arm of the Society, which has had a positive impact on my practice.
